Everolimus
NDC 63850-0062, Everolimus, tablet, from Natco Pharma Limited.
- Product NDC
- 63850-0062
- Status
- Listed
- Labeler
- Natco Pharma Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205432
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63850-0062 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EVEROLIMUS.25 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63850-0062-2 | 63850006202 | 6 BLISTER PACK in 1 CARTON (63850-0062-2) / 10 TABLET in 1 BLISTER PACK (63850-0062-3) |
| 63850-0062-6 | 63850006206 | 60 TABLET in 1 BOTTLE (63850-0062-6) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d44998bb-5deb-4ee7-a0a5-979fe3f49557
Use it
Look up 63850-0062 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63850-0062 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63850-0062. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.